Papaloucas C D, Papaloucas M D, Kouloulias V, Neanidis K, Pistevou-Gompaki K, Kouvaris J, Zygogianni A, Mystakidou K, Papaloucas A C
Democritus University, Alexandroupolis, Greece.
Peloponnese University, Sparta, Greece.
Med Hypotheses. 2014 Jan;82(1):24-5. doi: 10.1016/j.mehy.2013.10.028. Epub 2013 Nov 9.
The possible elevation of phosphorous (P) in cancer patients blood serum has been reported in the past. This however seems to have passed unnoticed. One hundred individuals, divided into two groups of fifty each, i.e. cancer patients (group A) and healthy individuals (group B), were included in this retrospective study. The incidence of cancer by site in group A was 24% head and neck, 50% non-small cell lung cancer (SCLC) and 26% cervical cancer. In all cancer patients in group A the serum P was over the normal values, in contrast with the normal values of P measured in group B. The mean value of serum P in group A and B were 7.80 (± 2.24) and 3.38 (± 0.58), respectively (P<0.001, Mann Whitney test). Increased amount of phosphorus in the blood, when other causes justifying the increase were excluded, should be considered as indicative for the existence of unidentified cancerous lesions.
过去已有报道称癌症患者血清中的磷(P)可能会升高。然而,这似乎未引起人们的注意。这项回顾性研究纳入了100人,分为两组,每组50人,即癌症患者(A组)和健康个体(B组)。A组中按部位划分的癌症发病率为:头颈部24%,非小细胞肺癌(SCLC)50%,宫颈癌26%。与B组测得的P正常数值相比,A组所有癌症患者的血清P均高于正常值。A组和B组血清P的平均值分别为7.80(±2.24)和3.38(±0.58)(P<0.001,曼-惠特尼检验)。当排除其他可解释磷升高的原因时,血液中磷含量的增加应被视为存在未确诊癌性病变的指征。